Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons

Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of the motor system with complex determinants, including genetic and non-genetic factors. A key pathological signature of ALS is the cytoplasmic mislocalization and aggregation of TDP-43 in affected motor neurons, which is found in 9...

Descripció completa

Dades bibliogràfiques
Autors principals:	Dafinca, R, Tosat-Bitrian, C, Carroll, E, Vahsen, BF, Gilbert-Jaramillo, J, Scaber, J, Feneberg, E, Johnson, E, Talbot, K
Format:	Journal article
Idioma:	English
Publicat:	Oxford University Press 2024

Ítems similars

Human stem cell models of neurodegeneration: from basic science of amyotrophic lateral sclerosis to clinical translation
per: Giacomelli, E, et al.
Publicat: (2022)

Amyotrophic lateral sclerosis: the complex path to precision medicine
per: Talbot, K, et al.
Publicat: (2018)

Understanding the role of microglia in the pathogenesis of amyotrophic lateral sclerosis
per: Vahsen, BF
Publicat: (2022)

Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosis
per: Nikel, LM, et al.
Publicat: (2024)

Regulation of mitochondria-dynactin interaction and mitochondrial retrograde transport in axons
per: Catherine M Drerup, et al.
Publicat: (2017-04-01)

What is the role of TDP-43 in C9orf72-related amyotrophic lateral sclerosis and frontemporal dementia?
per: Scaber, J, et al.
Publicat: (2016)

Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers
per: Vahsen, BF, et al.
Publicat: (2021)

TDP-43 based biomarker development in amyotrophic lateral sclerosis
per: Feneberg, E
Publicat: (2019)

Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients
per: Csaba Konrad, et al.
Publicat: (2017-10-01)

The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis.
per: Turner, M, et al.
Publicat: (2010)

Amyotrophic lateral sclerosis with a heterozygous D91A SOD1 variant and classical ALS-TDP neuropathology
per: Feneberg, E, et al.
Publicat: (2020)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
per: Turner, B, et al.
Publicat: (2008)

The pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutations
per: Scaber, J
Publicat: (2017)

Initial identification of a blood-based chromosome conformation signature for aiding in the diagnosis of amyotrophic lateral sclerosis
per: Salter, M, et al.
Publicat: (2018)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
per: Ansorge Olaf, et al.
Publicat: (2008-10-01)

Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway.
per: Timothy G Lesnick, et al.
Publicat: (2008-01-01)

Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis.
per: Yuta Iwai, et al.
Publicat: (2016-01-01)

Plasma taurine is an axonal excitability-translatable biomarker for amyotrophic lateral sclerosis
per: Tomoko Nakazato, et al.
Publicat: (2022-06-01)

Genetics of sporadic amyotrophic lateral sclerosis.
per: Schymick, J, et al.
Publicat: (2007)

Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis
per: Thompson, AG, et al.
Publicat: (2021)

Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain
per: Thompson, AG, et al.
Publicat: (2022)

Acute retigabine‐induced effects on myelinated motor axons in amyotrophic lateral sclerosis
per: Boudewijn T. H. M. Sleutjes, et al.
Publicat: (2022-08-01)

Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis
per: Eva P. Cuevas, et al.
Publicat: (2024-03-01)

Biomarkers in amyotrophic lateral sclerosis.
per: Turner, M, et al.
Publicat: (2009)

Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS)
per: Naoki Suzuki, et al.
Publicat: (2020-03-01)

Increased axonal ribosome numbers is an early event in the pathogenesis of amyotrophic lateral sclerosis.
per: Mark H G Verheijen, et al.
Publicat: (2014-01-01)

Defective cholesterol metabolism in amyotrophic lateral sclerosis.
per: Abdel-Khalik, J, et al.
Publicat: (2016)

CSF chitinase proteins in amyotrophic lateral sclerosis
per: Thompson, A, et al.
Publicat: (2019)

Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair
per: Ababneh, NA, et al.
Publicat: (2020)

Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral SclerosisResearch in context
per: Matthew Salter, et al.
Publicat: (2018-07-01)

Sweet food preference in amyotrophic lateral sclerosis
per: Turner, M, et al.
Publicat: (2017)

Phosphorylated CRMP1, axon guidance protein, is a component of spheroids and is involved in axonal pathology in amyotrophic lateral sclerosis
per: Yuko Kawamoto, et al.
Publicat: (2022-09-01)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis.
per: Gray, E, et al.
Publicat: (2015)

Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction
per: Gordon, D, et al.
Publicat: (2018)

Amyotrophic lateral sclerosis: Cell vulnerability or system vulnerability?
per: Talbot, K
Publicat: (2014)

Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?
per: Talbot, K
Publicat: (2014)

Structural basis for the rescue of hyperexcitable cells by the amyotrophic lateral sclerosis drug Riluzole
per: David Hollingworth, et al.
Publicat: (2024-09-01)

Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly.
per: Pereira, E, et al.
Publicat: (2010)

Evolution of the eukaryotic dynactin complex, the activator of cytoplasmic dynein
per: Hammesfahr Björn, et al.
Publicat: (2012-06-01)

Investigating mechanisms of TDP-43 toxicity in cellular models of amyotrophic lateral sclerosis
per: Carroll, E
Publicat: (2022)